These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 150344)

  • 1. Eruptions. Possible involvement of carrier contained in cutaneous tissues.
    Suzuki S; Asai Y; Hamada T; Mizoguchi Y; Yamada T; Morisawa S
    Dermatologica; 1978; 157(3):146-53. PubMed ID: 150344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocyte transformation test in the drug eruptions--the significance of cutaneous fractions as carrier (author's transl)].
    Suzuki S; Asai Y; Hamada T; Mizoguchi Y; Yamada T
    Nihon Hifuka Gakkai Zasshi; 1977 Aug; 87(9):531-5. PubMed ID: 144200
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte transformation test in fixed drug eruption.
    Gimenez-Camarasa JM; Garcia-Calderon P; de Moragas JM
    N Engl J Med; 1975 Apr; 292(16):819-21. PubMed ID: 123037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current findings on drug eruptions].
    Krebs A
    Z Hautkr; 1984 Dec; 59(23):1581-99. PubMed ID: 6240839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
    J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized fixed drug eruption caused by pazufloxacin.
    Sawada Y; Nakamura M; Tokura Y
    Acta Derm Venereol; 2011 Sep; 91(5):600-1. PubMed ID: 21597677
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective study of cutaneous drug reactions.
    Puavilai S; Timpatanapong P
    J Med Assoc Thai; 1989 Mar; 72(3):167-71. PubMed ID: 2525591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Desired and undesired effects of drugs on the skin].
    Steigleder GK
    Hautarzt; 1973 Jun; 24(6):261-71. PubMed ID: 4269262
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro interleukin-5 (IL-5) production by peripheral blood mononuclear cells from patients with drug hypersensitivity.
    Mikami C; Ochiai K; Kagami M; Tomioka H; Tanabe E
    J Dermatol; 1996 Jun; 23(6):379-81. PubMed ID: 8708148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.
    Kano Y; Hirahara K; Mitsuyama Y; Takahashi R; Shiohara T
    Allergy; 2007 Dec; 62(12):1439-44. PubMed ID: 17983378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
    Yanase K; Imamura S
    Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contact allergy to antibiotics].
    Ebner H
    Wien Klin Wochenschr; 1973 Mar; 85(13):203-4. PubMed ID: 4266367
    [No Abstract]   [Full Text] [Related]  

  • 14. Practolol-induced drug eruption.
    Assem ES; Banks RA
    Proc R Soc Med; 1973 Feb; 66(2):179-81. PubMed ID: 4145974
    [No Abstract]   [Full Text] [Related]  

  • 15. [Polyclonal T lymphocyte proliferation in drug lymphocyte activation test].
    Martin S; Barbaud A; Schmutz JL; Gobert B; Faure G; Bene MC
    Ann Dermatol Venereol; 2000 Mar; 127(3):268-72. PubMed ID: 10804299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study of clinical significance of leucocyte migration test in drug eruption].
    Abe M; Uno K
    Arerugi; 1998 Dec; 47(12):1264-72. PubMed ID: 10028721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug eruptions: causative agents and clinical types. A series of in-patients during a 10-year period.
    Kauppinen K; Stubb S
    Acta Derm Venereol; 1984; 64(4):320-4. PubMed ID: 6209890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Skin pathology caused by drugs].
    Lodi A; Betti R; Masnada MC; Chiarelli G; Cattaneo M
    Minerva Med; 1985 Nov; 76(42):1991-4. PubMed ID: 2933598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline/doxycycline-induced cutaneous depressed pigmentation.
    Adişen E; Gürer MA; Erdem O
    Int J Dermatol; 2006 Oct; 45(10):1245-7. PubMed ID: 17040455
    [No Abstract]   [Full Text] [Related]  

  • 20. Fixed drug eruption: primary site involvement on maximal points of Head's zones.
    Ozkaya E
    Acta Derm Venereol; 2007; 87(6):517-20. PubMed ID: 17989890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.